No abstract available
Keywords:
antithrombin III deficiency; enteropathy; purpura; thrombotic vasculopathy; ulcerative colitis.
PubMed Disclaimer
Conflict of interest statement
References
-
-
Komatsu Y.C., Capareli G.C., Boin M.F., Lellis R., Freitas T.H., Simone K. Skin gangrene as an extraintestinal manifestation of inflammatory bowel disease. An Bras Dermatol. 2014;89(6):967–969. doi: 10.1590/abd1806-4841.20143001.
-
DOI
-
PMC
-
PubMed
-
-
Cheeley J., Morales-Pico B., John S. Cutaneous thrombotic vasculopathy related to poorly controlled ulcerative colitis. JAAD Case Rep. 2018;4(7):672–674. doi: 10.1016/j.jdcr.2018.03.021.
-
DOI
-
PMC
-
PubMed
-
-
Miklusiak K., Miklusiak K., Kaczmarczyk O., Cibor D., Zwolińska-Wcisło M. Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn's disease. Dermatol Reports. 2023;15(3):9630.
-
PMC
-
PubMed
-
-
Gallo Marin B., Aghagoli G., Hu S.L., Massoud C.M., Robinson-Bostom L. Calciphylaxis and kidney disease: a review. Am J Kidney Dis. 2023;81(2):232–239. doi: 10.1053/j.ajkd.2022.06.011.
-
DOI
-
PubMed
-
-
Nazarian R.M., Van Cott E.M., Zembowicz A., Duncan L.M. Warfarin-induced skin necrosis. J Am Acad Dermatol. 2009;61(2):325–332. doi: 10.1016/j.jaad.2008.12.039.
-
DOI
-
PubMed